<code id='827F72CA2F'></code><style id='827F72CA2F'></style>
    • <acronym id='827F72CA2F'></acronym>
      <center id='827F72CA2F'><center id='827F72CA2F'><tfoot id='827F72CA2F'></tfoot></center><abbr id='827F72CA2F'><dir id='827F72CA2F'><tfoot id='827F72CA2F'></tfoot><noframes id='827F72CA2F'>

    • <optgroup id='827F72CA2F'><strike id='827F72CA2F'><sup id='827F72CA2F'></sup></strike><code id='827F72CA2F'></code></optgroup>
        1. <b id='827F72CA2F'><label id='827F72CA2F'><select id='827F72CA2F'><dt id='827F72CA2F'><span id='827F72CA2F'></span></dt></select></label></b><u id='827F72CA2F'></u>
          <i id='827F72CA2F'><strike id='827F72CA2F'><tt id='827F72CA2F'><pre id='827F72CA2F'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:1

          How does a drug industry lobbying group move forward after years of upheaval, including having four CEOs in four years?

          This week on “The Readout LOUD,” STAT’s Chief Washington Correspondent Rachel Cohrs Zhang joins us to discuss the layoffs at trade group BIO and how things may be changing at the trade group. We also invite STAT reporter Eric Boodman on to talk about his new investigative series of stories exploring how Black women with sickle cell disease were coerced into getting sterilized.

          advertisement

          To read the first article in the Coercive Care investigative series and find future installments, go here; For more on the layoffs at BIO, go here; To keep tabs on health policy and BIO’s reorganization, sign up for the D.C. Diagnosis newsletter here; And you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          leisure time

          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more
          Why patients can’t get everything they want on drug pricing
          Why patients can’t get everything they want on drug pricing

          AdobeYoudon’thavetobeaneconomisttounderstandthelawofdemand:Thehighertheprice,thelesslikelyacustomeri

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Senate panel puts off hardest PBM reforms for another day

          SenateFinanceCommitteeChairRonWyden(D-Ore.)LeahMillis/PoolviaAPWASHINGTON—SenatorsontheFinanceCommit